Shattuck Labs, Inc.

NASDAQ:STTK

Biotechnology

Healthcare
$4.47 +2.33%

+$0.11 today

Market cap
$455.24M
Beta
1.09
P/E (TTM)
-10.9
EPS (TTM)
-$0.44
52W Low $0.71High $8.33

Volume 2.08M

Average 0.69M

STTK Total Current Liabilities

All obligations due within one year.

Shattuck Labs, Inc.NASDAQ: STTK

Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total current liabilities falls 41.9% from a year ago

Total current liabilities stood at $4.25M at the end of Q1 FY2026, down 41.9% from a year earlier and down 39.7% from the prior quarter. Over 3 fiscal years it compounded at -34.4% a year.

Context

  • Total current liabilities amounted to 4.2% of total assets at the end of Q1 FY2026, down 5.3 pp from a year earlier.
  • Total current liabilities increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total current liabilities keeps falling in the next quarterly balance sheet after a -41.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.25M-39.7% QoQ
Last fiscal yearDec 2025
$7.05M-20.9% YoY
Year agoMar 2025
$7.32M-41.9% since
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-41.9%——
1 year-20.9%——
3-year CAGR-34.4%——
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

USD · from the balance sheet

Latest · FY2025
7.05M USD
Year-over-year change
-20.9%
4-year CAGR
-26.8%

Total Current Liabilities vs competitors

How STTK compares with its peers on the latest reported figures

  • STTK's Mar 2026 total current liabilities of $4.25M is the 8th highest of the 10 companies compared; the peer median is $10.15M.
  • Its year-over-year change of -41.9% is the 7th highest of 10, against a peer median of -15.9%.
  • Total current liabilities amounts to 4.2% of total assets for STTK, versus a peer median of 10.7%.
STTK Competitors Peer median
Total Current Liabilities for STTK and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IOVAIovance Biotherapeutics, Inc.Sep 2026$105.77M -15.9%+14.8%10.7%
PBYIPuma Biotechnology, Inc.Mar 2026$59.74M -31.1%+1.6%31.0%
BDTXBlack Diamond Therapeutics, Inc.Mar 2026$14.53M -13.7%+1.0%10.9%
CBIOCrescent Biopharma, Inc.Mar 2026$14.19M +442.4%+59.6%7.1%
PDSBPDS Biotechnology CorporationMar 2026$10.15M -44.4%-1.2%41.1%
FTHFaeth Therapeutics, Inc.Jun 2026$9.58M +147.4%-22.3%5.1%
SLSSELLAS Life Sciences Group, Inc.Sep 2026$9.29M +56.7%-23.2%6.6%
STTKShattuck Labs, Inc.Mar 2026$4.25M -41.9%-34.4%4.2%
NBPNovaBridge BiosciencesDec 2025$3.84M -93.8%-82.0%10.3%
INDPIndaptus Therapeutics, Inc.Mar 2026$933K -64.3%+21.5%42.8%
Peer median (excluding STTK) $10.15M-15.9%+1.0%10.7%

Competitors are the stored peer set for STTK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents92.27M47.38M125.63M57.39M54.19M
Short-term Investments176.54M113.9M5M15.6M23.87M
Net Receivables00000
Inventory00000
Other Current Assets023.3M12.6M6.23M4.41M
Total Current Assets288.27M184.58M143.22M79.22M82.48M
Property, Plant & Equipment (Net)9.94M17.67M13.8M9.81M6.11M
Goodwill00000
Intangible Assets00000
Long-term Investments00001M
Tax Assets00000
Other Non-current Assets381K3.07M2.54M2.02M1.44M
Total Non-current Assets10.32M20.74M16.34M11.83M8.55M
Total Assets298.59M205.32M159.56M91.05M91.03M
Account Payables10.01M7.17M1.59M2.42M2.1M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities11.25M5.84M4.84M2.7M3M
Total Current Liabilities24.59M24.97M11.45M8.92M7.05M
Long-term Debt00001.58M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.21M0000
Total Non-current Liabilities2.21M4.2M3.41M2.51M1.58M
Total Liabilities26.8M29.17M14.86M11.42M8.64M
Common Stock5K5K5K5K7K
Retained Earnings(117.07M)(219.01M)(306.31M)(381.72M)(430.53M)
Accumulated OCI(560K)(877K)4K2K6K
Other Stockholders Equity00000
Minority Interest00000
Total Equity271.79M176.16M144.71M79.63M82.39M
Total Debt04.9M4.2M3.41M2.42M
Net Debt(92.27M)(42.48M)(121.42M)(53.98M)(51.77M)

Shattuck Labs, Inc.

NASDAQ:STTK

Intrinsic Alpha fair value

Locked

Current Price

$4.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.